Archive for January 2020
Report: Mass. economy grew in third quarter, slowed in fourth
Labor constraints, remain a drag, preventing businesses from adding workers to payrolls. Read More
Read MoreFive things you need to know today, and why we’re sometimes bad at hiring
Good morning! Here are the 5 Things You Need to Know in Boston business news today. Read More
Read MoreFamilies of rare-disease patients take on drug development, but face uphill battle
Frustrated with the slow pace of drug discovery and desperate to help their loved ones, untrained family members take the work into their own hands by starting biopharma companies. But few such companies have been successful. Read More
Read MoreGillette parent P&G to close most Art of Shaving stores
Procter & Gamble plans to close a large majority of the company’s 83 retail stores operated by one of its brands. Read More
Read MoreStaples launches revamped stores in Greater Boston — complete with podcast studios
Staples is looking to revamp customers’ shopping experience, and plans to offer space for co-working and recording a podcast. Read More
Read MoreBoston Marathon organizers name Amazon ‘official retailer’ of race
E-commerce giant Amazon Inc. will become a top sponsor of this year’s Boston Marathon, the nonprofit behind the race said. Read More
Read MoreCVS offers a zero co-pay diabetes plan with tighter drug restrictions
The Rhode Island company’s pharmacy benefit manager now offers a way for diabetes patients to get care with zero co-pays, saying it will lower health care costs for this costly population in the long-term. Read More
Read MoreDana-Farber expands in renovated Methuen office
Marcus Partners recently invested $25 million to upgrade 5 Branch St. in Methuen. Read More
Read MoreBoston universities prep campuses for possibility of coronavirus
School officials from the Massachusetts Institute of Technology, Northeastern University, the University of Massachusetts, Tufts University and Emerson College are taking steps to keep their communities updated as the situation evolves. Read More
Read MoreBiogen touts ‘resilience’ but gives little guidance on Alzheimer’s drug
Biogen’s CEO Michel Vounatsos painted the drugmaker as a resilient fighter during a year-end investor call Thursday, while laying out the strategy for several major crusades that lie ahead. Read More
Read More